TRIPP
In an exclusive interview, the companies discuss their partnership and TRIPP's investment in Equa Health's pre-seed funding round.
TRIPP PsyAssist will provide protocols and anxiety-easing support to patients undergoing ketamine-assisted therapy.
This new infusion of cash brings the company's total funding to $15M.